Our licensing team structures complex intellectual property and technology transfer agreements that unlock the significant financial value inherent in life sciences innovations, working closely with our high-tech and M&A practices.
Strategic licensing agreements, collaborations, and alliances are critical revenue drivers in the life sciences sector, enabling companies to access new technologies, expand market reach, and accelerate development timelines. These arrangements often represent substantial financial opportunities, whether through technology access, distribution partnerships, or joint development initiatives. Our team structures agreements that maximize both immediate commercial returns and long-term strategic positioning.
Working closely with our high-tech and M&A practices, we negotiate sophisticated arrangements addressing complex valuation challenges, risk allocation, and performance metrics.
contact the department >